文献速递肺血管病与心包/心肌炎

他汀类药物与静脉血栓栓塞症二级预防:已发表观察性队列研究的汇总分析

Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies.
PubMed 文献 · Eur Heart J · 2017-01-01

该系统综述与荟萃分析纳入8项观察性队列研究共103 576名参与者及13 168例复发性VTE结局,汇总7项研究显示他汀使用与未使用相比复发性VTE的RR为0.73(0.68-0.79),复发性PE的RR为0.75(0.58-0.96),DVT的RR为0.66(0.60-0.71)。结论认为观察性证据提示他汀对VTE复发可能有益,需设计良好的干预研究证实。

要点

  • 汇总7项研究,他汀使用与未使用相比复发性VTE的RR为0.73(0.68-0.79)。
  • 复发性PE的RR为0.75(0.58-0.96),复发性DVT的RR为0.66(0.60-0.71)。
  • 研究间异质性I2=0%(0-71%),P=0.93,无显著异质性证据。

核心结论

  • 观察性队列研究证据提示他汀使用对VTE复发可能有益。
  • 需要设计良好的干预研究来证实这些发现。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE、Web of Science及手动检索参考文献,从建库至2017年1月。
  • 纳入8项报告他汀使用与复发性VTE结局关联的观察性队列研究,共103 576名参与者,13 168例复发性VTE结局。
  • 使用随机效应模型汇总研究特异性相对危险度(RR)及95%置信区间。

主要发现

  • 汇总7项研究,他汀使用与未使用相比复发性VTE的RR为0.73(95%CI 0.68-0.79)。
  • 研究间异质性I2=0%(0-71%),P=0.93,无显著异质性证据。
  • 3项研究汇总,他汀使用与未使用相比复发性PE的RR为0.75(95%CI 0.58-0.96)。
  • 2项研究汇总,他汀使用与未使用相比复发性DVT的RR为0.66(95%CI 0.60-0.71)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: There have been suggestions that statins may have a potential role in secondary prevention of venous thromboembolism (VTE) [which includes deep vein thrombosis (DVT) and pulmonary embolism (PE)], but the evidence is inconsistent. We aimed to evaluate the association between statin use and risk of recurrent VTE. METHODS AND RESULTS: We conducted a systematic review and meta-analysis of observational cohort studies. All relevant studies which reported associations between statin use and recurrent VTE outcomes were identified from MEDLINE, EMBASE, Web of Science, and manual search of bibliographies from inception to January 2017. Study specific relative risks (RRs) with 95% confidence intervals were aggregated using random effects models. Eight eligible studies comprising of 103 576 participants and 13 168 recurrent VTE outcomes were included in the pooled analysis. In pooled analysis of 7 studies, the RR for recurrent VTE was 0.73 (0.68-0.79) when comparing statin use with no use. There was no evidence of heterogeneity between contributing studies (I2=0%, 0-71%; P = 0.93). The RRs for recurrent PE (three studies) and DVT (two studies) comparing statin use with no statin use were 0.75 (95% CI: 0.58-0.96) and 0.66 (95% CI: 0.60-0.71) respectively. CONCLUSION: Available evidence from observational cohort studies suggests a beneficial effect of statin use on VTE recurrence. Well-designed intervention studies are needed to corroborate these findings.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kunutsor SK, Seidu S, Khunti K, et al. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies. Eur Heart J. 2017. PMID: 28369602. doi:10.1093/eurheartj/ehx107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。